Birgitta-A
Sat May 30, 2009, 05:04 AM
Hi All,
Now the first results from trials with Sapacitabine are presented: In the ongoing MDS stratum thus far 31 patients aged above 60 years have been treated with Sapacitabine as second line therapy following treatment with hypomethylating agents. Complete remission and hematological improvement have been observed in 7 patients.
http://production.investis.com/cyc/investors/news/pressreleases/2009/2009-05-29/
Kind regards
Birgitta-A
Now the first results from trials with Sapacitabine are presented: In the ongoing MDS stratum thus far 31 patients aged above 60 years have been treated with Sapacitabine as second line therapy following treatment with hypomethylating agents. Complete remission and hematological improvement have been observed in 7 patients.
http://production.investis.com/cyc/investors/news/pressreleases/2009/2009-05-29/
Kind regards
Birgitta-A